Kleinmuntz Associates logo

Kleinmuntz Associates

Crunchbase
Pitchbook
Crunchbase

Deals on record

1

Common Fundraising Type

Equity

VedaBio logo
VedaBio

Biotechnology

OMX Ventures logo
Kleinmuntz Associates logo

VedaBio has developed the CRISPR Cascade platform, a near-instant molecular detection technology that aims to become the gold standard for molecular detection in various applications, including research tools, diagnostics, and therapeutics.

Equity
$40M
10/17/2023
Article